Romiplostim: A novel thrombopoiesis-stimulating agent
Dátum: 30.10.2009 16:24
Vec: Trombocytopenia
Romiplostim: A novel thrombopoiesis-stimulating agent
Sarah Perreault and Julianna Burzynski
American Journal of Health-System Pharmacy, Vol. 66, Issue 9, 817-824
SARAH PERREAULT, PHARMD., is Clinical Oncology Pharmacist; and. JULIANNA BURZYNSKI, PHARM.D., is Clinical Pharmacy Specialist, Department of Pharmacy, Mayo Clinic, Rochester, MN.
Address correspondence to Dr. Perreault at the Department of Pharmacy, Mayo Clinic, 200 First Street, Rochester, MN 55901 (perreault.sarah@mayo.edu).
Index terms: Costs; Dosage; Drug administration; Mechanism of action; Pharmacokinetics; Purpura; Quality of life; Romiplostim; Thrombopoietic agents; Toxicity
pozri abstrakt
|
|